[ad_1]
Summary
[AstraZeneca: el ensayo de la nueva vacuna de la corona ha seguido todas las revisiones necesarias y no puede comentar sobre casos individuales]According to various media reports on October 21, Brazil’s National Health Supervision Agency stated that a participant in Oxford’s cooperation with AstraZeneca (AZN.US) The 28-year-old Brazilian volunteer who developed the clinical trial of the new corona vaccine died, but the trial can still continue. It’s worth noting that Bloomberg cited a source familiar with the matter on October 21, stating that the dead volunteer had not been vaccinated. (Paper)
According to various media reports on October 21, Brazil’s National Health Supervision Agency stated that one person participated in Oxford and AstraZeneca (AZN.US)Cooperative research and developmentThe 28-year-old Brazilian volunteer participating in the clinical trial of the new corona vaccine died, but the trial was still allowed to continue. It’s worth noting that Bloomberg cited a source familiar with the matter on October 21, stating that the dead volunteer had not been vaccinated.
On October 23, The Paper contacted AstraZeneca China about this, and the other party replied that, “due to strict compliance with medical confidentiality and clinical trial regulations, we are unable to comment on individual cases in the trial. of the new corona vaccine in progress. All required review procedures have been followed. “
AstraZeneca China emphasizes that “All major medical events are monitored by experimental researchers and independent safety monitoring.CommitteeConduct a careful evaluation with regulatory agencies. These evaluations have not raised any concerns about whether the ongoing trials will be discontinued. “
Earlier, Reuters mentioned in a report that the University of Oxford confirmed its plan to continue the trial and said in a statement that after careful evaluation, “no one is concerned about the safety of clinical trials.”
Volunteer deaths add another layer to the safety of the new corona vaccineUncertainty. Before September 8, a volunteer in a clinical trial of the vaccine in the UK was also found to have an unexplained illness. According to media reports, his neurological symptoms were linked to a rare and severe transverse myelitis. Consistent, but the news has not been officially confirmed.
Since then, suspended clinical trials have been resumed in the UK, Brazil, India, and other countries, but in the United States, the resumption of clinical trials of AstraZeneca’s new corona vaccine has not been approved. Previously, Reuters cited four anonymous sources as saying the United States may resume testing this week.
(Source: The Paper)
(Editor in charge: DF353)
I solemnly declare: The purpose of this information disclosed by Oriental Fortune.com is to spread more information and has nothing to do with this booth.
[ad_2]